Literature DB >> 15793230

Altered hepatic and muscle substrate utilization provoked by GLUT4 ablation.

Mollie Ranalletta1, Hua Jiang, Jing Li, T S Tsao, Antine E Stenbit, Masayoshi Yokoyama, Ellen B Katz, Maureen J Charron.   

Abstract

Studies were conducted to explore altered substrate utilization and metabolism in GLUT4 null mice. Liver fatty acid synthase mRNA and fatty acid synthesis rates were dramatically increased in GLUT4 null mice compared with control mice and were supported by increased rates of the pentose phosphate pathway oxidative phase and sterol regulatory binding protein mRNA expression. Increased GLUT2 protein content, glucokinase mRNA, and glucose-6-phosphate in GLUT4 null mice may provide substrate for the enhanced fatty acid synthesis. Increased fatty acid synthesis, however, did not lead to hepatic triglyceride accumulation in GLUT4 null mice because of increased hepatic triglyceride secretion rates. GLUT4 null mice rapidly cleared orally administered olive oil, had reduced serum triglyceride concentrations in the fed and the fasted state, and increased skeletal muscle lipoprotein lipase when compared with controls. Oleate oxidation rates were increased in GLUT4 null skeletal muscle in association with mitochondrial hyperplasia/hypertrophy. This study demonstrated that GLUT4 null mice had increased hepatic glucose uptake and conversion into triglyceride for subsequent use by muscle. The ability of GLUT4 null mice to alter hepatic carbohydrate and lipid metabolism to provide proper nutrients for peripheral tissues may explain (in part) their ability to resist diabetes when fed a normal diet.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15793230     DOI: 10.2337/diabetes.54.4.935

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  9 in total

1.  Hypoglycemia, hyperglucagonemia, and fetoplacental defects in glucagon receptor knockout mice: a role for glucagon action in pregnancy maintenance.

Authors:  Sophia Ouhilal; Patricia Vuguin; Lingguang Cui; Xiu-Quan Du; Richard W Gelling; Sandra E Reznik; Robert Russell; Albert F Parlow; Clara Karpovsky; Nanette Santoro; Maureen J Charron
Journal:  Am J Physiol Endocrinol Metab       Date:  2011-12-13       Impact factor: 4.310

Review 2.  The role of mitochondria in the pathophysiology of skeletal muscle insulin resistance.

Authors:  Ines Pagel-Langenickel; Jianjun Bao; Liyan Pang; Michael N Sack
Journal:  Endocr Rev       Date:  2009-10-27       Impact factor: 19.871

3.  NURR1 activation in skeletal muscle controls systemic energy homeostasis.

Authors:  Leonela Amoasii; Efrain Sanchez-Ortiz; Teppei Fujikawa; Joel K Elmquist; Rhonda Bassel-Duby; Eric N Olson
Journal:  Proc Natl Acad Sci U S A       Date:  2019-05-20       Impact factor: 11.205

4.  Mechanisms underlying the resistance to diet-induced obesity in germ-free mice.

Authors:  Fredrik Bäckhed; Jill K Manchester; Clay F Semenkovich; Jeffrey I Gordon
Journal:  Proc Natl Acad Sci U S A       Date:  2007-01-08       Impact factor: 11.205

5.  Antioxidant Effects of N-Acetylcysteine Prevent Programmed Metabolic Disease in Mice.

Authors:  Maureen J Charron; Lyda Williams; Yoshinori Seki; Xiu Quan Du; Bhagirath Chaurasia; Alan Saghatelian; Scott A Summers; Ellen B Katz; Patricia M Vuguin; Sandra E Reznik
Journal:  Diabetes       Date:  2020-05-22       Impact factor: 9.461

6.  PPARdelta regulates glucose metabolism and insulin sensitivity.

Authors:  Chih-Hao Lee; Peter Olson; Andrea Hevener; Isaac Mehl; Ling-Wa Chong; Jerrold M Olefsky; Frank J Gonzalez; Jungyeob Ham; Heonjoong Kang; Jeffrey M Peters; Ronald M Evans
Journal:  Proc Natl Acad Sci U S A       Date:  2006-02-21       Impact factor: 11.205

7.  Ceramide is a cardiotoxin in lipotoxic cardiomyopathy.

Authors:  Tae-Sik Park; Yunying Hu; Hye-Lim Noh; Konstantinos Drosatos; Kazue Okajima; Jonathan Buchanan; Joseph Tuinei; Shunichi Homma; Xian-Cheng Jiang; E Dale Abel; Ira J Goldberg
Journal:  J Lipid Res       Date:  2008-05-30       Impact factor: 5.922

8.  Maternal substrate utilization programs the development of the metabolic syndrome in male mice exposed to high fat in utero.

Authors:  Kirsten Hartil; Patricia M Vuguin; Michael Kruse; Esther Schmuel; Ariana Fiallo; Carlos Vargas; Matthew J Warner; Jorge L Durand; Linda A Jelicks; Maureen J Charron
Journal:  Pediatr Res       Date:  2009-10       Impact factor: 3.756

9.  Acute inhibition of fatty acid import inhibits GLUT4 transcription in adipose tissue, but not skeletal or cardiac muscle tissue, partly through liver X receptor (LXR) signaling.

Authors:  Beth A Griesel; Juston Weems; Robert A Russell; E Dale Abel; Kenneth Humphries; Ann Louise Olson
Journal:  Diabetes       Date:  2010-01-26       Impact factor: 9.461

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.